Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;222(1):42-43.
doi: 10.1016/j.rceng.2021.08.001. Epub 2021 Oct 21.

Predicting COVID-19 progress with clinical scales

V Estrada  1 , J González Del Castillo  2
Affiliations
Editorial

Predicting COVID-19 progress with clinical scales

V Estrada et al. Rev Clin Esp (Barc). 2022 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Julián-Jiménez A., García D.E., González del Castillo J., Penna Guimaraes H., García-Lamberechts E.J., Menéndez E., et al. Puntos clave sobre la COVID-19 en los servicios de urgencias: propuestas de mejora para su atención en Latinoamérica. Emergencias. 2021;33:42–58. - PubMed
    1. Zhou Y., Guo S., He Y., Zuo Q., Liu D., Xiao M., et al. COVID-19 is distinct from SARS-CoV-2-negative community-acquired pneumonia. Front Cell Infect Microbiol. 2020;10:322. doi: 10.3389/fcimb.2020.00322. - DOI - PMC - PubMed
    1. Gutiérrez Gabriel S., Domínguez García M.J., Pérez Mañas G., Moreno García N., Silvan Domínguez M., Andrés E.M. Marcadores y seguimiento tras alta de urgencias en neumonías COVID-19. Emergencias. 2021;33:174–180. - PubMed
    1. Gil-Rodrigo A., Miró O., Piñera P., Burillo-Putze G., Jiménez S., Martín A., et al. Evaluación de las características clínicas y evolución de pacientes con COVID-19 a partir de una serie de 1000 pacientes atendidos en servicios de urgencias españoles. Emergencias. 2020;32:233–241. - PubMed
    1. RECOVERY Collaborative Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645. doi: 10.1016/S0140-6736(21)00676-0. - DOI - PMC - PubMed